Medicines Expertise
FIP Development Goal 14 Education & Workforce Element
Globally, we will have:
Strategies and systems in place to prepare and train a workforce that can deliver quality medicines expertise.
Mechanisms
- Ensure academic capacity (FIP Development Goal 1 [w]) to deliver education and training to enhance medicines expertise in initial education.
- Incorporate expert information and advice provision skills in early career training strategy (FIP Development Goal 2 [w]) and continuing professional development strategies (FIP Development Goal 9).
- Utilise advanced and specialist development systems and frameworks (FIP Development Goal 4 [w]) to develop medicines expertise as an advanced or specialist area for the workforce, in addition to being embedded within leadership development programmes (FIP Development Goal 6 [w]).
- Incorporate medicines expertise competencies and skills in competency development frameworks for pharmacy (FIP Development Goal 5 [w]).
FIP Development Goal 14 Practice Element
Globally, we will have:
Strategies and systems in place on pharmaceutical expert information and advice provision to patients, formal and informal caregivers, health care professionals and relevant agencies and stakeholders.
Mechanisms
- Provide medicines and medical devices expertise and advice to patients, formal and informal caregivers, health care professionals and relevant agencies and stakeholders to inform policymaking, clinical decision-
making and prescribing practices, individual health care options and other medicines or medical devices related decisions. - Empower patients, formal and informal caregivers, and communities by increasing health literacy towards better care and self-care.
- Utilise appropriate communication and counselling pathways and skills to provide quality and appropriate information, taking into considerations cultural and language factors and other specific care needs (e.g. people with functional diversity, migrant and refugee populations, etc).
- Utilise formal resources including formularies and medicines information management systems to convey objective, evidence-based and systematically organised information about medicines and medical devices to support pharmacy practice and service delivery, as well as the practice of other healthcare professionals.
FIP Development Goal 14 Science Element
Globally, we will have:
Encourage provision of science-based information on medicines.
Mechanisms
- Promote responsible use of medicines by mobilising medicines expertise.
- Implement high-value cognitive services to review and optimise medicines use.
11 January 2022
Community pharmacists have a crucial role to play in responsible over-the-counter pain management (2021)
Read Publication
11 January 2022
Patient Safety: Pharmacists’ role in “Medication without harm” (2020)
Read Publication
6 January 2022
Joint Statement by the International Pharmaceutical Federation (FIP) and The World Self-Medication Industry (WSMI): Responsible Self-Medication (1998)
Read more
6 January 2022
Joint Statement by the International Pharmaceutical Federation (FIP) and The World Self-Medication Industry (WSMI): Responsible Self-Medication (1999)
Read more
6 January 2022
FIP Statement of Policy: Strategic development of medicines information for the benefit of patients and users of medicines (2017)
Read more
6 January 2022
Use of medicines by the elderly: The role of pharmacy in promoting adherence (2018)
Read more
9 December 2024
Artificial Intelligence in Drug Development and Clinical Trials
5 December 2024
Use of doxycycline for the prevention of bacterial sexually transmitted infections (STIs) (DoxyPEP): Supporting evidence and the challenge of antimicrobial resistance (AMR)
26 November 2024
Alcohol consumption and dependence: The role of pharmacists in prevention, support and management
20 November 2024
Reframing the role and impact of pharmacy in Chronic Obstructive Pulmonary Disease (COPD) Care
18 October 2024
Empowering pharmacists in menopause care: Expanding roles and patient support
17 October 2024
Use of heat therapy for the management of musculoskeletal pain in the community pharmacy: New FIP guidance
11 July 2024
Empoderar a los farmacéuticos para apoyar la deshabituación tabáquica en la región de las Américas
2 July 2024
Empowering pharmacists to support tobacco cessation in the Eastern Mediterranean Region
25 June 2024
Empowering pharmacists to support tobacco cessation in Western Pacific Region
31 May 2024
Leveraging pharmacists for tobacco cessation: New policy tools, evidence, and success stories
26 April 2024
How can pharmacists support patients with co-morbidities in preventing fatty liver disease?
25 April 2024
How can pharmacists support individuals living with fatty liver disease?
In this second episode of FIP’s CPD bite series on self-care approaches for fatty liver disease management explores how pharmacists can support a holistic approach to the care of patients with fatty liver disease.
19 April 2024
What is fatty liver disease and who is most at risk of developing it? (available in Polish and Romanian subtitles)
In this first episode of this FIP CPD bite series on self-care approaches for fatty liver disease management shares an overview of the epidemiology of fatty liver disease, its pathophysiology, its global burden, and the main risk groups and risk factors.
20 March 2024
The role of pharmacists in the prevention and management of periodontal disease and other common oral health conditions
4 March 2024
Obesity: understanding the disease, nutritional approaches and new pharmacological interventions
1 February 2024
Optimising cancer care: community pharmacy strategies to support patients on oral treatment
30 January 2024
Climate change and vector-borne neglected tropical diseases: Positioning pharmacy practice to drive awareness, prevention and management
16 March 2023
The role of pharmacists in the prevention and management of sleep disorders
2 February 2023
Latest developments on the causes of symptomatic reflux
This video discusses the pharmacological options for managing reflux. You will learn about the different types of medicines, their mechanisms of action, and some advantages and disadvantages of the traditional approaches to these symptoms.
2 February 2023
Symptoms of gastro-oesophageal reflux disease
This video explores the treatment options for reflux, including lifestyle changes, dietary modifications, and the use of non-prescription medicines. It shows some considerations that can be useful when approaching patients with reflux symptoms
13 December 2022
Provision of medical advice
This episode focuses on the provision of medical advice and the ethical dilemmas that pharmacists can face
22 November 2022
Non-pharmacological treatment approaches
This video focuses on non-pharmacological approaches to sore throat management and presents some tips for pharmacists to support self-care in this area.
22 November 2022
Pharmacological treatment approaches
This video summarises the main pharmacological treatment approaches for sore throat, focusing on an overview of the different preparations pharmacists can recommend when advising on sore throat management
11 November 2022
Pharmacological approaches and treatments for chronic bronchitis
In this video you may learn about pharmacological approaches and treatments for chronic bronchitis
24 October 2022
Facilitating access to medicines: Biowaiver regulatory case studies from Latin America
28 April 2022
Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults
26 April 2022
The role of community pharmacies in COVID-19 booster vaccination: Opportunities and supply chain challenges in a post-pandemic scenario
3 February 2022
In Vitro In Vivo (IVIV) Correlations: Establishing a correlation between in vitro tests and in vivo product performance
10 December 2021
FIP “Setting goals for the decade ahead” | Episode 20 | FIP DG 14: Medicines expertise
12 November 2021
Transforming pharmacy practice for improved care and management of diabetes
16 September 2021
Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Europe region
16 September 2021
Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Eastern Mediterranean Region
16 September 2021
Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Southeast Asia region
26 January 2021
Manufacturing Classification System for oral solid dosage forms: Good in theory and in practice
26 January 2021
Manufacturing Classification System for oral solid dosage forms: Good in Theory and in Practice
20 January 2021
The pharmacy practice research journey – Moving from your research idea to publication
20 January 2021
The pharmacy practice research journey – Moving from your research idea to publication
26 October 2020
American Association of Pharmaceutical Scientists annual meeting
Annual meeting
6 March 2019
EUFEPS annual meeting
EUFEPS is proud and happy to announce the 2019 Annual Meeting to be held in Frankfurt, Germany between March 6 - 8, 2019
1 September 2014
Shelf life and compounding: rationale and safe measures to mitigate drug shortages
Bob DeChristoforo, USA, Session A2, FIP congress Bangkok 2014The following FIP programmes of work and structures support the implementation of this Goal:
